Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: The residual SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score

Journal of the American College of Cardiology

Volumn 59, Issue 24, 2012, Pages 2165-2174

  Généreux, Philippe ^a,b   Palmerini, Tullio ^c   Caixeta, Adriano ^d   Rosner, Gregg ^a   Green, Philip ^a   Dressler, Ovidiu ^a   Xu, Ke ^a   Parise, Helen ^a   Mehran, Roxana ^e   Serruys, Patrick W ^f   Stone, Gregg W ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ACS; incomplete revascularization; PCI; SYNTAX score

Indexed keywords

ADULT; AGE; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SMOKING; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; HEALTH STATUS INDICATORS; HUMANS; MULTIVARIATE ANALYSIS; PROGNOSIS; RETREATMENT; RISK ASSESSMENT;

EID: 84861867540     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.03.010     Document Type: Article

References (34)

1. Rogers WJ, Bourassa MG, Andrews TC, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP investigators. J Am Coll Cardiol 1995; 26:594-605.
2. Hannan EL, Racz M, Holmes DR, et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006;113:2406-12. (Pubitemid 43948048)
3. Hannan EL, Wu C, Walford G, et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. J Am Coll Cardiol Intv 2009;2:17-25.
4. Kim YH, Park DW, Lee JY, et al. Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass graft surgery for multivessel coronary artery disease. Circulation 2011;123:2373-81.
5. van den Brand MJ, Rensing BJ, Morel MA, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002;39:559-64. (Pubitemid 34158148)
6. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91. (Pubitemid 351365675)
7. Head SJ, Mack MJ, Holmes DR Jr., et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg 2012;41:535-41.
8. Invasive compared with non-invasive treatment in unstable coronaryartery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999;354:708-15.
9. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-27.
10. Valgimigli M, Serruys PW, Tsuchida K, et al. Cyphering the complexity of coronary artery disease using the SYNTAX score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007; 99:1072-81. (Pubitemid 46562516)
11. Capodanno D, Capranzano P, Di Salvo ME, et al. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. J Am Coll Cardiol Intv 2009;2:731-8.
12. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2009;2:302-8.
13. Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol 2011;57:2389-97.
14. Kim YH, Park DW, Kim WJ, et al. Validation of SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. J Am Coll Cardiol Intv 2010;3:612-23.
15. Wykrzykowska JJ, Garg S, Girasis C, et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol 2010;56:272-7.
16. Girasis C, Garg S, Raber L, et al. SYNTAX score and clinical syntax score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J 2011;32: 3115-27.
17. Garg S, Sarno G, Girasis C, et al. A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. J Am Coll Cardiol Intv 2011;4:645-53.
18. Garg S, Serruys PW, Silber S, et al. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. J Am Coll Cardiol 2011;4:432-41.
19. Magro M, Nauta S, Simsek C, et al. Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: the MI SYNTAXscore study. Am Heart J 2011;161:771-81.
20. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006;355:2203-16. (Pubitemid 44791162)
21. Stone GW, White HD, Ohman EM, et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Lancet 2007; 369:907-19. (Pubitemid 46400858)
22. Genereux P, Palmerini T, Caixeta A, et al. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv 2011;4:553-61.
23. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
24. Srinivas VS, Selzer F, Wilensky RL, et al. Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI dynamic registry. J Interv Cardiol 2007;20:373-80. (Pubitemid 47429137)
25. Kloeter UC, Jander NG, Buser PT, Osswald S, Mueller-Brand J, Pfisterer ME. Long-term outcome of angioplasty for multivessel coronary disease: importance and price of complete revascularization. Int J Cardiol 2001;79:197-205. (Pubitemid 32673681)
26. Nikolsky E, Gruberg L, Patil CV, et al. Percutaneous coronary interventions in diabetic patients: is complete revascularization important? J Invasive Cardiol 2004;16:102-6. (Pubitemid 38326316)
27. Tamburino C, Angiolillo DJ, Capranzano P, et al. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents. Catheter Cardiovasc Interv 2008;72:448-56.
28. Aggarwal V, Rajpathak S, Singh M, Romick B, Srinivas VS. Clinical outcomes based on completeness of revascularisation in patients undergoing percutaneous coronary intervention: a meta-analysis of multivessel coronary artery disease studies. EuroIntervention 2012;7: 1095-102.
29. Ijsselmuiden AJ, Ezechiels J, Westendorp IC, et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am Heart J 2004;148:467-74. (Pubitemid 39265120)
30. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 1981;63:285-99.
31. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16. (Pubitemid 46588415)
32. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
33. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the fame study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010;55:2816-21.
34. Nam CW, Mangiacapra F, Entjes R, et al. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011;58:1211-8.